Annual Statements Open main menu

RICHARDSON ELECTRONICS, LTD. - Quarter Report: 2003 February (Form 10-Q)

FORM10Q-RELL2QFY02

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

[ X ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended _________February 28, 2003 __________

OR

[   ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period from __________________ to _____________________

Commission file number 0-12906

 

RICHARDSON ELECTRONICS, LTD.
(Exact name of registrant as specified in its charter)
DELAWARE
(State of incorporation or organization)
36-2096643
(I.R.S. Employer Identification No.)
40W267 Keslinger Road, PO Box 393, LaFox, Illinois 60147
(Address of principal executive offices and zip code)
(630) 208-2200
(Registrant's telephone number, including area code)


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requiremens for the past 90 days.

YES [ X ]   NO [   ]

As of April 7, 2003, there were outstanding 12,194,829 shares of Common Stock, $.05 par value, inclusive of 1,557,428 shares held in treasury, and 3,206,812 shares of Class B Common Stock, $.05 par value, which are convertible into Common Stock on a share-for-share basis.

This Quarterly Report on Form 10-Q contains 28 pages. An exhibit index is at page 23.


Richardson Electronics, Ltd. and Subsidiaries
Form 10-Q
For the Three- and Nine-Month Periods Ended February 28, 2003

INDEX

  Page
PART I - FINANCIAL INFORMATION  
Consolidated Condensed Balance Sheets
3
Consolidated Condensed Statements of Operations
4
Consolidated Condensed Statements of Cash Flows
5
Notes to Consolidated Condensed Financial Statements
6

Management's Discussion and Analysis of Results
     of Operations and Financial Condition


16
PART II - OTHER INFORMATION 23

 


Richardson Electronics, Ltd. and Subsidiaries
Consolidated Condensed Balance Sheets
(in thousands)

  February 28
2003 (Unaudited)
May 31
2002

ASSETS

 

Current Assets:    
     Cash and equivalients $   12,383 $   15,485
     Receivables, less allowance of $3,436 and $2,646 82,916 84,156
     Inventories 111,343 107,159
     Other 21,212
20,999
          Total current assets 227,854 227,799

     Property, plant and equipment

61,713

55,232
          Less accumulated depreciation (31,125)
(26,405)
               Property, plant and equipment, net 30,588 28,827

     Goodwill

4,243

24,914

     Other assets

3,968


5,296

          Total assets $ 266,653
$ 286,836

LIABILITES AND STOCKHOLDERS' EQUITY
   
Current liabilities:    
     Accounts payable $ 21,332 $ 27,387
     Accrued expenses 13,088 13,631
     Notes payable and current portion of long-term debt 42
38
          Total current liabilities 34,462 41,056

Long-term debt, less current portion

140,961

132,218
Deferred income taxes 4,160 8,764
Non-current liabilities 5,229
5,195
          Total liabilities 184,812 187,233

Stockholders' equity:
   
     Common stock, $.05 par value; issued 12,179 shares at
        February 28, 2003 and 12,144 at May 31, 2002

608

607
     Class B common stock, convertible, $.05 par value; issued
        3,207 at Februry 28, 2003 and at May 31, 2002

160

160
     Additional paid-in capital 91,312 91,013
     Common stock in treasury, at cost; 1,557 shares at
        February 28, 2003 and 1,584 at May 31, 2002

(9,229)

(9,386)
     Retained earnings 18,411 36,420
     Accumulated other comprehensive loss (19,421)
(19,211)
          Total stockholders' equity 81,841
99,603
          Total liabilities and stockholders' equity $ 266,653
$ 286,836

 

See Notes to Consolidated Condensed Financial Statements


Richardson Electronics, Ltd. and Subsidiaries
Consolidated Condensed Statements of Operations
For the Three- and Nine-Month Periods Ended February 28, 2003 and 2002
(unaudited) (in thousands, except per share amounts)

  Three Months
Nine Months
  FY 2003
FY 2002
FY 2003
FY 2002
Net sales $118,010 $109,431 $345,582 $329,611
Cost of products sold 89,808
83,151
261,313
248,476
     Gross margin 28,202 26,280 84,269 81,135
Selling, general and administrative expenses 25,451
23,427
74,155
70,281
          Operating income 2,751 2,853 10,114 10,854

Other (income) expense:
       
     Interest expense 2,537 2,589 7,430 9,716
     Investment income 9 (14) (123) (285)
     Other, net 215
4,551
513
4,839
2,761
7,126
7,820
14,270
        Income (loss) before income taxes and cumulative
        effect of accounting change
(10) (4,273) 2,294 (3,416)
Income taxes (5)
(1,530)
825
(1,221)
        Net income (loss) before cumulative effect of accounting change (5) (2,743) 1,469 (2,195)
Cumulative effect of accounting change, net of tax (Note B) -
-
(17,862)
-
          Net loss $      (5)
$ (2,743)
$ (16,393)
$ (2,195)
Net income (loss) per share - basic:
        Net income (loss) per share before cumulative effect
          of accounting change
$    - $    (.20) $    .11 $    (.16)
Cumulative effect of accounting change, net of tax (Note B) -
-
(1.30)
-
        Net loss per share $    -
$     (.20)
$    (1.19)
$     (.16)
        Average shares outstanding 13,805
13,656
13,791
13,599
Net income (loss) per share - diluted:        
        Net income (loss) per share before cumulative effect
          of accounting change
$    - $    (.20) $    .11 $    (.16)
Cumulative effect of accounting change, net of tax (Note B) -
-
(1.28)
-
        Net loss per share $    -
$    (.20)
$     (1.17)
$    (.16)
        Average shares outstanding 13,805
13,656
13,989
13,599
Dividends per common share $    .04
$    .04
$     .12
$     .12
Comprehensive income (loss):        
     Net loss $       (5) $ (2,743) $ (16,393) $ (2,195)
     Foreign currency translation 2,034 (743) 87 (185)
     SFAS 133 transition adjustment - - - (971)
     Fair value adjustment - cash flow hedges (44)
80
(297)
240
          Comprehensive income (loss) $   1,985
$ (3,406)
$ (16,603)
$ (3,111)

 

See Notes to Consolidated Condensed Financial Statements


Richardson Electronics, Ltd. and Subsidiaries
Consolidated Condensed Statements of Cash Flows
For the Nine-Month Periods Ended February 28, 2003 and 2002
(Unaudited) (in thousands)

FY 2003
FY 2002
Operating Activites:
     Net loss $ (16,393) $  (2,195)
     Non-cash charges to income:
          Depreciation 4,072 4,158
          Amortization 201 489
          Deferred income taxes (66) (590)
          Cumulative effect of a change in accounting principle 17,862 -
          Charge related to disposition of a business - 4,551
          Other 660
2,280
               Total non-cash charges 22,729
10,888
Changes in working capital, net of effects of
   currency translation and business acquisitions:
     Accounts receivable 4,783 11,069
     Inventories (3,218) 8,377
     Other current assets (628) (7,240)
     Accounts payable (7,515) 1,075
     Other Liabilities (1,009)
(5,645)
          Net changes in working capital (7,587)
7,636
          Net cash provided by (used in) operating activities (1,251)
16,329
Financing Activities:
     Proceeds from borrowings 29,538 19,407
     Payments on debt (23,847) (25,333)
     Proceeds from stock issuance 204 671
     Cash dividends (1,617)
(1,609)
          Net cash provided by (used in) financing activities 4,278
(6,864)
Investing Activities:
     Capital expenditures (4,958) (4,112)
     Business acquisitions (764) (8,716)
     Proceeds from sale of business - 6,261
     Other (407)
202
          Net cash used in investing activities (6,129)
(6,365)
          Increase (decrease) in cash and equivalents (3,102) 3,100
Cash and equivalents at beginning of year 15,485
15,946
          Cash and equivalents at end of period $ 12,383
$ 19,046

 

See Notes to Consolidated Condensed Financial Statements


Richardson Electronics, Ltd. and Subsidiaries
Notes to Consolidated Condensed Financial Statements
Three- and Nine-Month Periods Ended February 28, 2003 and 2002
(Unaudited)


Note A -- Basis of Presentation
The accompanying unaudited Consolidated Condensed Financial Statements (Statements) have been prepared in accordance with generally accepted accounting principles for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) necessary for a fair presentation have been included. Operating results for the three-month and nine-month periods ended February 28, 2003 are not necessarily indicative of the results that may be expected for the year ended May 31, 2003.
For further information, refer to the consolidated financial statements and footnotes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended May 31, 2002.

Note B -- Goodwill and Other Intangible Assets
In June 2001, the Financial Accounting Standards Board issued SFAS No. 141, Business Combinations, and SFAS No. 142, Goodwill and Other Intangible Assets, effective for fiscal years beginning after December 15, 2001. SFAS No. 141 requires business combinations initiated after June 30, 2001 to be accounted for using the purchase method of accounting. Under SFAS No. 142, goodwill and intangible assets deemed to have indefinite lives will no longer be amortized but will be subject to annual impairment testing in accordance with the statements. Other intangible assets will continue to be amortized over their useful lives.

The Company applied the new rules on accounting for goodwill and other intangible assets beginning in the first quarter of fiscal 2003, and, accordingly discontinued the amortization of goodwill and other intangible assets not subject to amortization.

The following table presents a reconciliation of reported net income (loss) to adjusted net income (loss) excluding amortization of goodwill and other intangible assets not subject to amortization, net of taxes, (in thousands, except per-share amounts):

  For the Periods Ended February 28, 2003 and 2002
  Three Months
Nine Months
  FY 2003
FY 2002
FY 2003
FY 2002

Reported net loss

  $          (5)   $   (2,743)   (16,393)   $   (2,195)

Add back amortization of goodwill

- 81 - 249

Add back amortization of other intangible
   assets not subject to amortization

-
13
-
42

Adjusted net loss

  $          (5)
  $   (2,649)
  (16,393)
  $   (1,904)

Basic earnings per share:
       

Reported basic net loss per share

  $           -   $     (0.20)   $     (1.19)   $     (0.16)

Add back amortization of goodwill

- 0.01 - 0.02

Add back amortization of other intangible
   assets not subject to amortization

-
-
-
-

Adjusted basic net loss per share

  $           -
  $     (0.19)
  $     (1.19)
  $     (0.14)

Diluted earnings per share:
       

Reported diluted net loss per share

  $           -   $     (0.20)   $     (1.17)   $     (0.16)

Add back amortization of goodwill

- 0.01 - 0.02

Add back amortization of other intangible
   assets not subject to amortization

-
-
-
-

Adjusted diluted net loss per share

  $           -
  $     (0.19)
  $     (1.17)
  $     (0.14)

During the second quarter of fiscal 2003, the Company completed both steps of the required impairment tests of goodwill and indefinite lived intangible assets for each of the reporting units as required under the transitional accounting provisions of SFAS 142.

In identifying reporting units, the Company evaluated its reporting structure as of the date of adoption. The Company concluded that the following operating segments and their components qualified as reporting units: RF & Wireless Communications, Broadcast, Display Systems Group, Industrial Power Group, Burtek, and Security Systems Division excluding Burtek. The first step in the process of goodwill impairment testing is a screen for potential impairment of the goodwill and other long-lived assets, while the second step measures the amount of the impairment. The Company used a discounted cash flow valuation (income approach) to determine the fair value of each of the reporting units. Sales, operating income, and EBITDA multiples (market approaches) were used as a check against the impairment implications derived under the income approach. The first step indicated that goodwill and other long-lived assets of RF & Wireless Communications, Broadcast and Security Systems Division excluding Burtek were impaired. In evaluating the amount of impairment, it was determined that all goodwill and other long-lived assets were impaired for the aforementioned reporting units. Consequently, the Company recorded effective at the beginning of the first quarter of fiscal 2003, an impairment loss of $21.6 million of which $21.5 million related to goodwill with the balance attributable to other intangible assets with indefinite useful lives. The impairment loss of $17.9 million, net of tax of $3.7 million, was recorded as a cumulative effect of a change in accounting principle.

The table below provides changes in carrying value of goodwill by reportable segment (in thousands):

  Reportable Segments
  RFWC
IPG
SSD
DSG
Total

Goodwill at May 31,2002

$ 20,342 $   864 $   2,297 $   1,411 $ 24,914

   Additions

- - - 764 764

   Impairment loss

(20,345) - (1,131) - (21,476)

   Foreign currency translation

3
7
31
-
41

Goodwill at February 28,2003

$        -
$   871
$   1,197
$   2,175
$   4,243

The addition to goodwill recorded in the first quarter of fiscal 2003 represents additional consideration paid for certain business acquisitions made in prior periods due to the acquired businesses achieving certain targeted operating levels.

The following table provides changes in carrying value of other intangible assets not subject to amortization which represent incorporation and acquisition costs (in thousands):

  Reportable Segments
  RFWC
IPG
SSD
Total

Other intangible assets not subject to amortization at May 31,2002

$   111 $      9 $   373 $   493

   Impairment loss

(111) - - (111)

   Foreign currency translation

-
-
11
11

Other intangible assets not subject to amortization balance at February 28, 2003

$        -
$      9
$   384
$   393

Intangible assets subject to amortization as well as amortization expense are as follows (in thousands):

  February 28, 2003
May 31, 2002
  Gross Amount
Accumulated Amortization
Gross Amount
Accumulated Amortization

Intangible assets subject to amortization:

       

Deferred financing costs

$   3,158 $   2,543 $   2,852 $   2,335

Other intangible assets

478
445
478
436

Total intangible assets subject to amortization:

$   3,636
$   2,988
$   3,330
$   2,771

  Third Quarter
Nine Months
  FY 2003
FY 2002
FY 2003
FY 2002

Amortization of intangible assets subject to amortization

$      60
$      45
$     201
$      111

The amortization expense associated with the intangible assets subject to amortization is expected to be $277,000, $302,000, $183,000, $79,000 and $8,000 in fiscal 2003, 2004, 2005, 2006, and 2007, respectively. The weighted average number of years of amortization expense remaining is 3.0.

Note C -- Warranties
The Company offers warranty for specific products it manufactures. The Company also provides extended warranties for some products it sells that lengthen the period of coverage specified in the manufacturer's original warranty. Terms generally range from one to three years. Warranty reserves are established for costs that are expected to be incurred after the sale and delivery of products under warranty. The warranty reserves are determined based on known product failures, historical experience, and other currently available evidence.

Changes in the warranty reserve for the nine months ended February 28, 2003 were as follows (in thousands):

  Warranty Reserve

Balance at May 31, 2002

$         47

   Accruals for warranties issued during the period

509

   Utilization

(143)

Balance at February 28, 2003

$      413

The increase in the warranty accrual represents warranties reserved for sales related to a new product offering in the third quarter of fiscal 2003.

Note D -- Income Taxes
The income tax provisions for the three and nine-month periods ended February 28, 2003 and February 28, 2002 are based on the estimated annual effective tax rate of 36%, representing the U.S. statutory rate of 35% and the net effect of state and foreign subsidiary tax rates. Higher effective tax rates in foreign jurisdictions are offset by the tax benefits under the U.S. extra-territorial income tax laws and regulations.

Note E -- Calculation of Earnings per Share
Basic earnings per share is calculated by dividing net income by the weighted average number of Common and Class B Common shares outstanding. Diluted earnings per share is calculated by dividing net income (adjusted for interest savings, net of tax, on assumed bond conversions) by the actual shares outstanding and share equivalents that would arise from the exercise of stock options and the assumed conversion of convertible bonds when such assumptions have a dilutive effect on the calculation. The Company's 8 1/4 % and 7 1/4 % convertible debentures are excluded from the calculation in both fiscal 2003 and 2002 as assumed conversion would be anti-dilutive. The per share amounts presented in the Consolidated Condensed Statement of Operations are based on the following amounts (in thousands):

  Third Quarter
Nine Months
  FY 2003
FY 2002
FY 2003
FY 2002
Numerator for basic EPS:        

     Net income (loss) before
          cumulative effect of accounting change

$      (5) $ (2,743) $ 1,469 $ (2,195)

     Cumulative effect of accounting change

-
-
(17,862)
-

     Net loss

$      (5)
$ (2,743)
$ (16,393)
$ (2,195)
Denominator for basic EPS:        

     Beginning shares outstanding

13,789 13,614 13,767 13,470

     Additional shares issued

16
42
24
129

          Average shares outstanding

13,805
13,656
13,791
13,599

Numerator for diluted EPS:
       

     Net income (loss) before
          cumulative effect of accounting change

$      (5) $ (2,743) $ 1,469 $ (2,195)

     Cumulative effect of accounting change

-
-
(17,862)
-

     Net loss

$     (5) $ (2,743) $ (16,393) $ (2,195)

Interest savings, net of tax, on assumed conversion of bonds


-


-


-


-

          Adjusted net loss

$     (5)
$ (2,743)
$ (16,393)
$ (2,195)

Denominator for diluted EPS:
       

     Average shares outstanding

13,805 13,656 13,791 13,599

     Effect of dilutive stock options

- - 198 -

     Assumed conversion of bonds

-
-
-
-

          Average shares outstanding

13,805
13,656
13,989
13,599

Note F -- Pro-Forma Stock-Based Compensation
The Company has stock-based compensation plans under which stock options are granted to key managers at the market price on the date of grant. Grants were issued during the nine months ended February 28, 2003 and 2002 under stock-based compensation plans approved by shareholders. Most of these new grants are fully exercisable after five years and have a ten-year life.

According to SFAS No. 123, "Accounting for Stock-Based Compensation," the Company has elected to account for its employee stock option plans under APB Opinion No. 25, "Accounting for Stock Issued to Employees," which recognizes expense based on the intrinsic value at date of grant. As stock options have been issued with exercise prices equal to grant date fair value, no compensation cost has resulted. Had compensation cost for all options granted been determined based on the fair value at grant date consistent with SFAS No. 123, the Company's net earnings and earnings per share would have been as follows:

-
  For the Periods Ended February 28, 2003 and 2002
  Three Months
Nine Months
  FY 2003
FY 2002
FY 2003
FY 2002

Reported net loss

$      (5) $ (2,743) $ (16,393) $ (2,195)

     Pro-forma employee compensation expenses,
     net of taxes

240
240
719
720

Pro-forma net loss

$   (245)
$ (2,983)
$ (17,112)
$ (2,915)
Basic earnings per share:        

Reported net loss

$         - $   (0.20) $   (1.19) $   (0.16)

     Pro-forma employee compensation expenses,
     net of taxes

(0.02)
(0.02)
(0.05)
(0.05)

Pro-forma net loss

$   (0.02)
$   (0.22)
$   (1.24)
$   (0.21)
Diluted earnings per share:        

Reported net loss

$         - $   (0.20) $   (1.17) $   (0.16)

     Pro-forma employee compensation expenses,
     net of taxes

(0.02)
(0.02)
(0.05)
(0.05)

Pro-forma net loss

$   (0.02)
$   (0.22)
$   (1.22)
$   (0.21)

Note G -- Industry and Market Information
The marketing and sales structure of the Company consists of four strategic business units (SBU's): RF & Wireless Communications Group (RFWC), Industrial Power Group (IPG), Security Systems Division (SSD), and Display Systems Group (DSG).

RFWC serves the voice and data telecommunications market and the radio and television broadcast industry, predominately for wireless infrastructure applications.

IPG serves a broad range of markets including power supplies, automotive, industrial, semiconductor, alternative energy, medical, industrial maintenance and repair organizations, and audio/amplifier.

SSD provides security systems and related design services for the financial, building security, utilities, government, loss prevention, and transportation markets.

DSG provides system integration and custom product solutions for the medical imaging, custom display, public information, and government markets. The medical monitor business was integrated into DSG in fiscal 2002 and serves the medical imaging market.

In February 2002, the Company sold its Medical Glassware business including the reloading and distribution of X-ray, CT, and image intensifier tubes.

SBUs are managed by Vice Presidents and General Managers who report to the President and Chief Operating Officer. The President evaluates performance and allocates resources, in part, based on the direct operating contribution of each SBU. Direct operating contribution is defined as gross margin less product management and direct selling expenses. In each geographic area, certain sales force expenses are directly charged to SBUs. Other expenses, such as general sales force, regional sales management, and administrative and support expenses are shared and, accordingly, are not included in direct SBU expenses. Administrative expenses including finance, legal, information technology, human resources, logistics, and facility costs are not allocated to SBU results. Intersegment sales are not significant.

Accounts receivable, inventory, goodwill and certain notes receivable are identified by SBU. Cash, net property, plant and equipment, and other assets are not identifiable by SBU. Accordingly, depreciation and amortization of financing costs and certain intangible assets are not identifiable by SBU. Operating results for the three- and nine-month periods ended February 28, 2003 and February 28, 2002 and identifiable assets as of the end of the respective periods by SBU are summarized in the table below (in thousands). Fiscal 2002 DSG data has been reclassified to include medical monitors, which were previously reported within Medical Systems Group (MSG). The medical glassware business, which was sold in February 2002, is now displayed separately. The continuing activity in this segment represents the sale of remaining inventory. The reclassifications have been made to conform to the 2003 presentations.

Third Quarter Sales Margin Contribution Assets Goodwill
FY 2003




RFWC $   56,216 $   12,437 $   6,143 $   96,781 $       -
IPG 18,654 6,012 4,139 37,512 871
SSD 23,205 5,859 3,217 33,614 1,197
DSG 18,047 4,381 2,730 26,075 2,175
Medical Glassware 296
31
(20)
718
-
Total $  116,418 $  28,720 $  16,209 $  194,700 $ 4,243
FY 2002




RFWC $    48,911 $   11,081 $    5,536 $  126,309 $  19,582
IPG 17,486 5,644 4,022 42,991 898
SSD 21,353 4,967 2,626 34,766 2,550
DSG 15,718 4,283 2,549 28,460 1,487
Medical Glassware 3,855
762
230
3,473
-
Total $  107,323 $  26,737 $  14,963 $  235,999 $ 24,517





Nine monts Sales Margin Contribution Assets Goodwill
FY 2003




RFWC $ 166,403 $   37,412 $   18,958 $   96,781 $       -
IPG 57,123 18,903 13,527 37,512 871
SSD 69,601 17,306 9,671 33,614 1,197
DSG 46,169 11,977 7,110 26,075 2,175
Medical Glassware 1,140
218
43
718
-
Total $  340,436 $  85,816 $  49,309 $  194,700 $ 4,243
FY 2002




RFWC $   146,451 $   34,817 $   18,073 $   126,309 $   19,582
IPG 55,020 18,205 13,315 42,991 898
SSD 63,233 14,836 7,722 34,766 2,550
DSG 46,419 11,992 6,844 28,460 1,487
Medical Glassware 11,912
2,513
792
3,473
-
Total $  323,035 $  82,363 $  46,746 $  235,999 $ 24,517





A reconciliation of sales, gross margin, direct operating contribution and assets to the relevant consolidated amounts follows. (Other assets include miscellaneous receivables, manufacturing inventories and sundry assets.) (in thousands):

  Third Quarter
Nine Months
  FY2003
FY2002
FY2003
FY2002

Sales - segments total

$ 116,418 $ 107,323 $ 340,436 $ 323,035
Corporate 1,592
2,108
5,146
6,576

     Sales

$ 118,010
$ 109,431
$ 345,582
$ 329,611

Gross margin - segments total

$ 28,720 $ 26,737 $ 85,816 $ 82,363

Manufacturing variances and other costs

(518)
(457)
(1,547)
(1,228)
     Gross Margin $ 28,202
$ 26,280
$ 84,269
$ 81,135

Segment profit contribution

$ 16,209 $ 14,963 $ 49,309 $ 46,746

Manufacturing variances and other costs

(518) (457) (1,547) (1,228)

Regional selling expenses

(4,388) (3,840) (12,776) (11,276)
Administrative expenses (8,552)
(7,813)
(24,872)
(23,388)

     Operating income

$ 2,751
$ 2,853
$ 10,114
$ 10,854

Segment assets

$ 194,700 $ 235,999    

Cash and equivalents

12,383 19,046    
Other current assets 21,212 26,627    
Net property 30,588 27,956    
Other assets 7,770
3,481
   

      Total assets

$ 266,653
$ 313,109
   

The Company sells its products to customers in a wide range of industries and performs periodic credit evaluations of their financial condition. Terms are generally on open account, payable net 30 days in North America, and vary throughout Europe, Latin America and the Far East. Estimates of credit losses are recorded in the financial statements based on periodic reviews of outstanding accounts.


Management's Discussion and Analysis
of Results of Operations and Financial Condition
Three and Nine-Month Periods Ended February 28, 2003 and 2002
(Unaudited)


Results of Operations

Sales and Gross Margins
Consolidated sales for the third quarter and first nine months of fiscal 2003 increased 7.8% and 4.8% compared to the prior year's quarter and nine-month period, respectively, despite geopolitical concerns and a stagnant economy. Revenue from continuing operations (excluding Medical Glassware) increased 11.5% and 8.4% compared to the prior year's quarter and nine-month period, respectively. Consolidated gross margins edged down 10 basis points (bps) for the quarter and 20 basis points year-to-date compared to the prior year, primarily from higher manufacturing variances due to lower utilization rates. Sales, percentage changes from the prior year, gross margins and gross margin percent of sales by SBU are summarized in the following table. Warranty provisions, LIFO provisions, freight costs, obsolescence provisions, and gross margins from miscellaneous sales are included under the caption "Corporate" (in thousands).

  Sales
Gross Margin
FY 2003
FY 2002
%
Change

FY 2003
GM %
of Sales

FY 2002
GM %
of Sales

Third Quarter
RFWC $ 56,216 $ 48,911 14.9 % $ 12,437 22.1 % $ 11,081 22.7 %
IPG 18,654 17,486 6.7 % 6,012 32.2 % 5,644 32.3 %
SSD 23,205 21,353 8.7 % 5,859 25.2 % 4,967 23.3 %
DSG 18,047 15,718 14.8 % 4,381 24.3 % 4,283 27.2 %
Medical Glassware 296 3,855 - 92.3 % 31 10.5 % 762 19.8 %
Corporate 1,592
2,108
  (518)
  (457)
 
Total $ 118,010
$ 109,431
7.8 % $ 28,202
23.9 % $ 26,280
24.0 %
Total excluding
Medical Glassware $ 117,714 $ 105,576 11.5 % $ 28,171 23.9 % $ 25,518 24.2 %
Nine Months              
RFWC $ 166,403 $ 146,451 13.6 % $ 37,412 22.5 % $ 34,817 23.8 %
IPG 57,123 55,020 3.8 % 18,903 33.1 % 18,205 33.1 %
SSD 69,601 63,233 10.1 % 17,306 24.9 % 14,836 23.5 %
DSG 46,169 46,419 - 0.5 % 11,977 25.9 % 11,992 25.8 %
Medical Glassware 1,140 11,912 - 90.4 % 218 19.1 % 2,513 21.1 %
Corporate 5,146
6,576
  (1,547)
  (1,228)
 
Total $ 345,582
$ 329,611
4.8 % $ 84,269
24.4 % $ 81,135
24.6 %
Total excluding
Medical Glassware $ 344,442 $ 317,699 8.4 % $ 84,051 24.4 % $ 78,622 24.7 %

RFWC's third quarter sales increased 14.9% from fiscal 2002 levels, driven by a 32% growth in the United States. Sales for the nine-month period increased 13.6% from the prior year primarily from growth in Asia and the United States. These sales increases were mainly due to several large component sales to OEM customers with lower margins driving the decreases of 60 bps for the quarter and 130 bps year-to-date compared to fiscal 2002. In addition, margins were affected by lower factory utilization rates as orders for engineered solutions were delayed amid geopolitical concerns and a stagnant economy.

IPG sales increased by 6.7% in the third quarter as sales in Asia increased by 26.5% offset partially by declines in Canada and Latin America. Sales for IPG for the nine-month period increased 3.8% compared to the prior year. These increases were driven by sales of solid-state devices while legacy tube products were essentially flat.

SSD sales continued their upward trend increasing 8.7% compared to the third quarter of fiscal 2002 and 10.1% in the nine-month period compared to the prior year due to heightened concerns over security and acceleration in the conversion from analog to digital technology. Gross margins increased to 25.2% in the third quarter from 23.3% in the prior year due to improved mix and a higher proportion of sales in Canada and Europe. Gross margin trends were similar year-to-date compared to the prior year.

Following weak first and second quarters, DSG experienced a strong quarter with sales up 14.8% in the third quarter compared to the prior year due to the completion of certain large projects. For the nine-month period, the sales were 0.5% below 2002 levels, reflecting weakness in the first half of fiscal 2003 in transportation and financial services sectors as well as the timing of project scheduling. Gross margins decreased to 24.3% in the third quarter from particularly high levels of 27.2% in the same period in the prior year, which were driven primarily by the timing of project scheduling, whereas year-to-date gross margins were essentially flat at 25.9%.

The Medical Glassware sales decline of 92.3% in the third quarter from fiscal 2002 was the result of the Medical Glassware business sale completed in February of 2002. Fiscal 2002 sales and gross margins for MSG have been reclassified to include only Medical Glassware products to conform to the fiscal 2003 presentation. All other sales and gross margins previously reported as MSG have been reclassified to Corporate and DSG.

Sales, percentage change from the prior year, gross margins and gross margin percent of sales by geographic area are summarized in the following table. The caption, "US Export", includes sales to export distributors and to countries where the Company does not have offices. Warranty provisions, LIFO provisions, freight costs, obsolescence provisions, and gross margins from miscellaneous sales are included under the caption "Corporate" (in thousands).

  Sales
Gross Margin
FY 2003
FY 2002
%
Change

FY 2003
GM %
of Sales

FY 2002
GM %
of Sales

Third Quarter
North America $ 65,736 $ 60,509 8.6 % $ 16,526 25.1 % $ 15,289 25.3 %
Europe 25,983 22,908 13.4 % 6,681 25.7 % 6,020 26.3 %
Asia/Pacific 18,074 15,674 15.3 % 3,973 22.0 % 3,356 21.4 %
Latin America 5,004 6,555 -23.7 % 1,161 23.2 % 1,665 25.4 %
U.S. Export 1,621 1,677 - 3.3 % 379 23.4 % 407 24.3 %
Corporate 1,592
2,108
  (518)
  (457)
 
Total $ 118,010
$ 109,431
7.8 % $ 28,202
23.9 % $ 26,280
24.0 %
Nine Months              
North America $ 193,460 $ 181,378 6.7 % $ 49,112 25.4 % $ 46,495 25.6 %
Europe 73,347 68,380 7.3 % 19,300 26.3 % 18,155 26.6 %
Asia/Pacific 54,175 47,047 15.2 % 12,382 22.9 % 10,842 23.0 %
Latin America 15,039 20,807 -27.7 % 3,912 26.0 % 5,544 26.6 %
U.S. Export 4,415 5,423 - 18.6 % 1,110 25.1 % 1,327 24.5 %
Corporate 5,146
6,576
  (1,547)
  (1,228)
 
Total $ 345,582
$ 329,611
4.8 % $ 84,269
24.4 % $ 81,135
24.6 %

North America sales increased 8.6% in the third quarter from the prior year primarily due to sales growth in RFWC in the United States and strong SSD sales in Canada. The year-to-date sales trend for North America was similar to the prior year. Asia Pacific sales increased by approximately 15% in the third quarter and nine-month period due to a solid advance in RFWC sales. Europe sales grew 13.4% in the quarter and 7.3% year-to-date compared to last year, partially propelled by the strengthened Euro against the U.S. dollar, as well as some large project orders. Latin America sales declined 23.7% from the prior year's third quarter. Sales for the nine-month period for Latin America were down 27.7% compared to the prior year. The quarter and nine-month sales declines are a direct result of the economic downturn in the Latin American economies.

Fiscal 2003 gross margins were generally consistent with fiscal 2002 levels except Latin America, which experienced a gross margin decline of 220 bps in the third quarter as a result of increased competitive pressure in the weak economic environment.

Selling, General and Administrative Expenses
Compared to fiscal 2002, selling, general and administrative expenses increased 8.6% in the third quarter and 5.5% for the nine-month period. Foreign currency translation rates, merit increases, and higher incentives accounted for the majority of the increase. SG&A as a percent of revenues increased by 20 bps compared to prior year at 21.6% in the quarter and 21.5% year-to-date.

Interest and Other Expenses
Compared to fiscal 2002, interest expense decreased $52,000 and $2,286,000 for the three and nine-month periods, respectively, primarily due to lower borrowing levels at more favorable interest rates in fiscal 2003.

In addition, lower year-to-date interest expense in fiscal 2003 compared to fiscal 2002 is partially a result of the adoption of SFAS 133, Accounting for Derivative Instruments and Hedging Activities, for certain interest rate exchange agreements. The Company recorded a charge of $757,000 through the first nine months of fiscal 2002 to reflect the change in the fair value of these agreements. In fiscal 2003, the Company designated such agreements as hedges and has subsequently recorded any change in the fair value of such agreements to other accumulated comprehensive income.

Fiscal 2002 third quarter other expense includes a pre-tax charge of $4.6 million related to the sale of Glassware which was recorded to provide for the disposition of certain Glassware inventories not included in the sale, as well as warranty, severance and leasehold costs.

Net Results
Net loss for the third quarter of fiscal 2003 was $5,000 compared to a loss of $2,743,000 in the third quarter of the prior year. The impact of currency fluctuations in the quarter on revenues was offset by their impact on the SG&A, resulting in no overall effect on net earnings. For the nine-month periods, the Company recorded a net loss of $16,393,000 and $2,195,000 in fiscal 2003 and 2002, respectively. Included in the 2003 results is a goodwill and other intangible assets impairment charge in the amount of $17.9 million, net of taxes of $3.7 million. The impairment was recorded as a change in accounting principle in the first quarter of fiscal 2003. (See Note B to the Consolidated Financial Statements). Last year results reflect a net charge of $2.9 million related to the sale of the Medical Glassware product line completed in the third quarter of fiscal 2002.

Liquidity and Capital Resources
Cash and equivalents were $12.4 million at February 28, 2003, a decrease of $3.1 million from the beginning of the year. The decrease was primarily a result of cash used by operations of $1.2 million combined with capital expenditures of $5.0 million and dividend payments of $1.6 million partially offset by a net borrowings increase of $5.7 million.
Working capital increased $7.6 million in the nine months of fiscal 2003 primarily due to reductions in accounts payable of $7.5 million compared to the prior year.
In November of 2002, the Company entered into a new $102 million secured revolving credit facility with its current lending group. The new credit facility replaces existing credit lines and is principally secured by trade receivables and inventory. The new agreement provides significantly relaxed leverage and coverage ratios from the prior agreement while extending the maturity date to September 2005 with similar pricing.
The Company's loan and debenture agreements contain financial covenants, of which the most restrictive set benchmark levels for tangible net worth, senior funded debt to cash flow, cash flow to interest coverage, and senior funded debt relative to accounts receivable and inventory levels. The Company was in compliance with all covenants for the period ended February 28, 2003.
Cash reserves, investments, funds from operations and credit lines are expected to be adequate to meet the operational needs and future dividends of the Company. The policy regarding payment of dividends is reviewed periodically by the Board of Directors in light of the Company's operating needs and capital structure.

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995
Investors should consider carefully the following risk factors, in addition to the other information included in this quarterly report on Form 10-Q. All statements other than statements of historical facts included in this report are statements that constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934. The words "expect," "estimate," "anticipate," "predict," "believe" and similar expressions and variations thereof are intended to identify forward-looking statements. Such statements appear in a number of places in this report and include statements regarding the intent, belief or current expectations of the Company, its directors or its officers with respect to, among other things: (i) trends affecting the Company's financial condition or results of operations; (ii) the Company's financing plans; (iii) the Company's business and growth strategies, including potential acquisitions; and (iv) other plans and objectives for future operations. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties and that actual results may differ materially from those predicted in the forward-looking statements or which may be anticipated from historical results or trends. In addition to the information contained in the Company's other filings with the Securities and Exchange Commission, factors that could affect future performance include, among others, the following:

  • Competitive pressures may increase or change through industry consolidation, entry of new competitors, marketing changes or otherwise. There can be no assurance that the Company will be able to continue to compete effectively with existing or potential competitors.
  • Technological changes may affect the marketability of inventory on hand.
  • General economic or business conditions, domestic and foreign, may be less favorable than expected, resulting in lower sales or lower profit margins than expected.
  • Changes in relationships with customers or vendors, the ability to develop new relationships or the business failure of several customers or vendors may affect sales or profitability.
  • Political, legislative or regulatory changes may adversely affect the businesses in which the Company operates.
  • Changes in securities markets, interest rates or foreign exchange rates may adversely affect the Company's performance or stock price.
  • The failure to obtain or retain key executive or technical personnel could affect future performance.
  • The Company's growth strategy includes expansion through acquisitions. There can be no assurance that the Company will be able to successfully complete further acquisitions or that past or future acquisitions will not have an adverse impact on the Company's operations.
  • The potential future sale of Common Stock shares, possible anti-takeover measures available to the Company, dividend policies, as well as voting control of the Company by Edward J. Richardson, Chairman of the Board and Chief Executive Officer may affect the stock price.
  • The continued availability of financing on favorable terms cannot be assured.
Controls and Procedures
The Company's Chief Executive Officer and its Chief Financial Officer, after evaluating the effectiveness of the Company's disclosure controls and procedures (as defined in Exchange Act Rules 13a-14(c) and 15d-14(c)), have concluded that, as of February 28, 2003, the Company's disclosure controls and procedures were adequate and effective to ensure that material information relating to the Company and its consolidated subsidiaries would be made known to them by others within those entities.
There were no significant changes in the Company's internal controls or in other factors that could significantly affect the Company's disclosure controls and procedures subsequent to the date of the evaluation, nor were there any significant deficiencies or material weaknesses in the Company's internal controls. As a result, no corrective actions were required or undertaken.
Part II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

From time to time, the Company is engaged in legal proceedings arising in the normal course of business. These legal proceedings are not expected to have a material adverse effect on the Company.

ITEM 2. CHANGES IN SECURITIES

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

At the Annual Meeting of Stockholders held October 15, 2002, the management slate of directors ran unopposed and was elected.

Name
Number of Affirmative Votes
Withheld Authority

Edward J. Richardson

40,737,516 260,610

Scott Hodes

40,901,873 96,253

Samuel Rubinovitz

40,900,973 97,153

Arnold Allen

40,900,523 97,603

Jacques Bouyer

40,882,099 116,027

Dario Sacomani

40,737,154 260,972

Harold L.Purkey

40,902,123 96,003

Ad Ketelaars

40,902,373 95,753

Bruce W. Johnson

40,735,964 262,162

John R. Peterson

40,902,373 95,753

ITEM 5. OTHER INFORMATION

None.

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K

(a) Exhibits -

99       Statements of Edward J. Richardson, Chairman of the Board and Chief Executive Officer of Richardson Electronics, Ltd and
          Dario Sacomani, Senior Vice President and Chief Financial Officer of Richardson Electronics, Ltd,
          as required by Section 906 of the Sarbanes-Oxley Act of 2002.

(b) Reports on Form 8-K

Form 8-K dated January 14, 2003 announcing Richardson's fiscal 2003 third quarter dividend.

Form 8-K dated March 25, 2003 reporting Richardson's third quarter fiscal 2003 Earnings.

Form 8-K dated April 8, 2003 announcing Richardson's fiscal 2003 fourth quarter dividend.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Date: April 14, 2003

RICHARDSON ELECTRONICS, LTD.

By _\S\ Dario Sacomani _
Dario Sacomani
Senior Vice President and
Chief Financial Officer